Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

112
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
112
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

432
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
432
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

163
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
163
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

290
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
290
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

155
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
155
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

226
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
226

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Premorbid and postmorbid correlates of global neurocognitive dysfunction in bipolar disorder.

Journal of affective disorders·2026
Same author

Neuroprogression in Bipolar Disorder: The Evidence Really Matters.

Bipolar disorders·2026
Same author

Sociodemographic variables as predictors of antidepressant treatment outcome in major depressive disorder.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2026
Same author

A Critical Overview of the Validity of the Current Concept of Bipolar Disorder.

Journal of personalized medicine·2025
Same author

Effect of Bisphenol A on the neuro-immune-endocrine mechanisms controlling the reproductive axis response during an inflammatory event.

Environmental toxicology and pharmacology·2025
Same author

Neurodevelopment as an alternative to neuroprogression to explain cognitive functioning in bipolar disorder.

Psychological medicine·2024

Related Experiment Video

Updated: Dec 1, 2025

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

82.3K

Renal Damage During Continuous Versus Intermittent Treatment with Lithium.

Georgina P Ossani1,2,3, Ana M Uceda4,5, Osvaldo J Ponzo6

  • 1Centre of Experimental and Applied Pathology, Department of Pathology, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina. georginaossani@gmail.com.

Biological Trace Element Research
|November 6, 2020
PubMed
Summary

Lithium treatment, whether continuous or intermittent, causes kidney damage in rats. Continuous lithium administration appears to result in slightly greater renal histopathological damage compared to intermittent dosing.

Keywords:
Dosing regimenHistopathologyKidney damageLithium

More Related Videos

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

9.1K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.1K

Related Experiment Videos

Last Updated: Dec 1, 2025

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

82.3K
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

9.1K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.1K

Area of Science:

  • Nephrology
  • Pharmacology
  • Toxicology

Background:

  • Lithium is a widely used mood stabilizer, but its long-term effects on renal function require thorough investigation.
  • Understanding the renal impact of different lithium administration schedules (continuous vs. intermittent) is crucial for patient safety.

Purpose of the Study:

  • To compare the renal damage induced by continuous versus intermittent lithium treatment in an animal model.
  • To assess histopathological changes and key renal function markers following lithium administration.

Main Methods:

  • Rats were divided into control and two experimental groups receiving lithium (60 mmol/kg diet) continuously or intermittently for 3 months.
  • Renal function was evaluated by measuring diuresis, serum creatinine, and creatinine clearance.
  • Kidney tissues were examined for histopathological alterations, including hypertrophy, hyperplasia, and tubular dilatation.

Main Results:

  • Both continuous and intermittent lithium groups exhibited increased diuresis compared to controls.
  • No significant differences were observed in serum creatinine or creatinine clearance between groups.
  • Histopathological analysis revealed tubular hypertrophy, hyperplasia, and dilatation in both lithium-treated groups, with greater dilatation noted in the continuous treatment group.

Conclusions:

  • Histopathological renal damage occurs with both continuous and intermittent lithium treatment.
  • Continuous lithium administration may lead to more pronounced renal tubular dilatation than intermittent dosing.
  • Further long-term studies are warranted to fully elucidate the progression of lithium-induced nephropathy.